---

LIVECMECNERx

Tuesday, May 26, 2020, 1:00 PM - 2:30 PM, Other, Seattle, WA


AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician (Attendance) (1.50 hours), Nursing Contact Hour(s) (1.50 hours), Pharmacotherapeutics (1.50 hours)

The Seattle Neonatology Practice has a steroid protocol for use in premature babies with significant lung disease. Recent research has investigated the risk/benefit of longer duration of steroids and timing of steroids. During this webinar, the current RDS/BPD rates will be discussed and historical steroid use in the practice will be reviewed. New research will be examined to determine whether the Practice’s protocol should be revised.

1. Compare the Seattle Practice's current RDS and CLD rates and VON data
2. Review the current practice's steroid use protocol for premature infants with severe lung disease
3. Examine the research studies for longer steroid courses and the effect of timing for steroid treatment on outcomes
4. Discuss whether the current protocol should be changed in light of the new literature

1. Compare the Seattle Practice's current RDS and CLD rates and VON data
2. Review the current practice's steroid use protocol for premature infants with severe lung disease
3. Examine the research studies for longer steroid courses and the effect of timing for steroid treatment on outcomes
4. Discuss whether the current protocol should be changed in light of the new literature

NOTE: Registration is only open to Pediatrix Medical Group, Seattle Group clinicians.

The MEDNAX Center for Research, Education, Quality and Safety is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The MEDNAX Center for Research, Education, Quality and Safety designates this Internet Live Activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

---

The MEDNAX Center for Research, Education, Quality and Safety is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. (#PO258)

The MEDNAX Center for Research, Education, Quality and Safety designates this Internet Live Activity for a maximum of 1.50 nursing contact hour(s). Participants should only claim credit commensurate with the extent of their participation in the activity.

The MEDNAX Center for Research, Education, Quality and Safety designates this Internet Live activity for 1.50 pharmacotherapeutics contact hour(s).

The registration form for this activity Is currently unavailable.

There is no commercial support for this educational activity.